BB&T Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$2.13M Buy
29,100
+3,546
+14% +$249K 0.02% 563
2019
Q2
$1.57M Sell
25,554
-1,530
-6% -$92.5K 0.01% 655
2019
Q1
$1.73M Buy
27,084
+2,547
+10% +$145K 0.02% 630
2018
Q4
$1.25M Buy
24,537
+210
+0.9% +$10.6K 0.01% 674
2018
Q3
$1.41M Buy
24,327
+957
+4% +$46.8K 0.01% 712
2018
Q2
$1.13M Buy
23,370
+972
+4% +$45.4K 0.01% 769
2018
Q1
$1.04M Sell
22,398
-13,575
-38% -$590K 0.01% 770
2017
Q4
$1.35M Buy
35,973
+16,779
+87% +$616K 0.02% 647
2017
Q3
$699K Sell
19,194
-1,131
-6% -$43.1K 0.01% 866
2017
Q2
$801K Sell
20,325
-1,197
-6% -$43.7K 0.01% 816
2017
Q1
$674K Buy
21,522
+7,047
+49% +$221K 0.01% 789
2016
Q4
$581K Sell
14,475
-5,550
-28% -$180K 0.01% 787
2016
Q3
$804K Buy
20,025
+2,604
+15% +$98.1K 0.01% 684
2016
Q2
$578K Buy
17,421
+9,456
+119% +$324K 0.01% 758
2016
Q1
$234K Buy
+7,965
New +$220K ﹤0.01% 1031

Other funds holding EW

BB&T Securities's EW Position: Q3 2019 in Review

BB&T Securities increased its Edwards Lifesciences (EW) stake by 14% in Q3 2019, buying an estimated $249K and bringing the position to 29,100 shares worth $2.13M. The position accounts for 0.02% of the portfolio, ranked #563.

BB&T Securities first reported a position in EW in Q1 2016 and has held it in 15 quarters since. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • BB&T Securities held 29,100 shares of Edwards Lifesciences worth $2.13M as of Q3 2019.
  • BB&T Securities bought 3,546 Edwards Lifesciences shares in Q3 2019, an estimated $249K.
  • Edwards Lifesciences made up 0.02% of BB&T Securities's portfolio in Q3 2019, its #563 holding.
  • BB&T Securities first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 15 quarters since.
  • 965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.